Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes

NCT00097279 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic insulin aspart
DRUG: pioglitazone
DRUG: metformin

Sponsor

Novo Nordisk A/S